CIK 0001501697 · Non-accelerated filer<br>Smaller reporting company
X4 Pharmaceuticals, Inc
Sign in to watch- Ticker
- XFOR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 273181608
- Phone
- 857-529-8300
- Business address
- 61 NORTH BEACON STREET, 4TH FLOOR, BOSTON, MA, 02134
- Former names
- Arsanis, Inc.
- 10-Q Report Quarterly Report
- 8-K Event Other events
- 8-K Event Material agreement · Agreement ended · New debt or obligation · Unregistered share sale · Regulation FD disclosure
- 8-K Event Other events
- 8-K Event Other events
- 10-Q Report Quarterly Report
- 8-K Event Executive or director change · Regulation FD disclosure
- 8-K/A Event Executive or director change · Shareholder vote results
- 8-K Event Executive or director change · Shareholder vote results
- 10-Q Report Quarterly Report
- 10-K Report Annual Report
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Material agreement
- 8-K Event Exit or restructuring costs · Executive or director change · Regulation FD disclosure
- 8-K Event Executive or director change
- 8-K Event Material agreement · Unregistered share sale · Other events
- 8-K Event Material agreement · Unregistered share sale · Executive or director change · Other events
- 10-Q Report Quarterly Report
- 8-K Event Material agreement
Page 1 of 10 · 184 filings